Estimations des analystes de Wall Street pour TG Therapeutics, Inc. (TGTX): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-02 | $0.36 | ||
| 2026-08-03 | $0.05 | $0.31 | -83.6% |
| 2026-05-06 | $0.14 | $0.23 | -39.1% |
| 2026-02-26 | $0.14 | $0.35 | -60.0% |
| 2025-11-03 | $2.43 | $0.24 | +912.5% |
| 2025-08-04 | $0.17 | $0.32 | -46.9% |
| 2025-05-05 | $0.03 | $0.18 | -83.3% |
| 2025-03-03 | $0.15 | $0.08 | +87.5% |
Ratios de valorisation
| Ratio P/E | 18.34 |
| Prix / Valeur comptable | 13.11 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $152381 | $152381 | $152000 | $152000 | $152000 | $6.7M | $2.8M | $233.7M | $329.0M | $616.3M |
| Coût des Ventes | $62960 | $82355 | $88000 | 0 | 0 | $790000 | $265000 | $14.1M | $38.5M | $100.7M |
| Marge Brute | $89421 | $70026 | $64000 | $152000 | $152000 | $5.9M | $2.5M | $219.5M | $290.5M | $515.6M |
| R&D | $66.5M | $96.9M | $153.8M | $154.2M | $165.9M | $222.6M | $125.4M | $76.2M | $94.3M | $160.2M |
| Frais Généraux | $9.9M | $16.3M | $15.2M | $15.0M | $107.8M | $128.1M | $95.5M | $122.7M | $154.3M | $232.0M |
| Charges Opérationnelles | $79.1M | $118.9M | $174.6M | $169.2M | $273.7M | $350.7M | $220.8M | $198.9M | $248.6M | $392.2M |
| Résultat Opérationnel | -$79.0M | -$118.7M | -$174.4M | -$169.1M | -$273.6M | -$344.8M | -$218.3M | $20.6M | $41.9M | $123.3M |
| EBITDA | -$78.9M | -$118.4M | -$173.4M | -$167.3M | -$272.7M | -$342.0M | -$213.1M | $26.1M | $49.9M | $134.4M |
| Charges d'Intérêt | 0 | $1.1M | $1.7M | $5.3M | $6.3M | $5.6M | $10.2M | $12.6M | $24.0M | $26.7M |
| Résultat Avant Impôts | -$78.3M | -$118.5M | -$173.5M | -$172.9M | -$279.4M | -$348.1M | -$223.8M | $13.1M | $25.6M | $107.4M |
| Impôts | -$716234 | -$235739 | -$918000 | 0 | 0 | 0 | 0 | $390000 | $2.2M | -$339.8M |
| Résultat Net | -$78.3M | -$118.5M | -$173.5M | -$172.9M | -$279.4M | -$348.1M | -$223.8M | $12.7M | $23.4M | $447.2M |
| BPA | $-1.60 | $-1.91 | $-2.30 | $-1.96 | $-2.42 | $-2.63 | $-1.46 | $0.09 | $0.16 | $3.10 |
| BPA Dilué | $-1.60 | $-1.91 | $-2.30 | $-1.96 | $-2.42 | $-2.63 | $-1.46 | $0.09 | $0.15 | $2.77 |
| Actions en Circulation (Diluées) | $49.0M | $62.1M | $75.5M | $88.4M | $115.3M | $132.2M | $135.4M | $148.5M | $160.3M | $161.4M |
Prix
| Prix | $55.85 |
| Capitalisation | $8.5B |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ACLX · ALKS · ARWR · CRSP · IMVT · KRYS · KYMR
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de TGTX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions